Aspira women's health regained compliance with nasdaq's minimum bid price requirement

Austin, texas, june 02, 2023 (globe newswire) -- aspira women's health inc. (“aspira”) (nasdaq: awh), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, announced today that it has received notification from the listing qualifications department (“the staff”) of the nasdaq stock market (“nasdaq”) that aspira has regained compliance with the nasdaq minimum bid price requirement, as is required for continued listing on the nasdaq capital market pursuant to nasdaq listing rule 5550(a)(2) (the “bid price requirement”), based on achieving the minimum closing bid price per share for 10 consecutive business days. the notice also indicated that because the company is now in compliance with the bid price requirement, nasdaq considers the matter closed.
AWH Ratings Summary
AWH Quant Ranking